Although other IL-17A producing cells, including γδT cells and innate lymphoid cells, may also be involved in IECs-induced IL-17A response in the colon, these results indicate that epithelial costimulatory molecules could be potential therapeutic targets for Th17-mediated disorders such as IBD. Here, IL17A is linked to inflammatory bowel disease.